Wall Street is Short VBIV, but I'm Long Target: [$3.50]

Link to Culper Research report that states they are shorting VBIV because the company is "worthless"
img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/Culper_VBIV_6-2-2020.pdf?ver=1591103388750

First, it's always important to consider ALL information. It's also important to be transparent about knowledge. If you are going to make any VBIV trades you really should read the entire report.

1) I think many of the points made in the Culper Report are legitimate
2) I am not as optimistic about long term price targets as those seen at Guggenheim and on yahoo finance
3) I still believe this is a good short-term trade based on sentiment and momentum regarding June 22-24 release of clinical glioblastoma data

Stop loss @ $2.04

交易結束：目標達成

Closed trade at $2.41 today